Venom Peptides as a Rich Source of Cav2.2 Channel Blockers
Silmara Rodrigues de Sousa(The University of Queensland), Richard J. Lewis(AstraZeneca (Netherlands)), Irina Vetter(Centre National de la Recherche Scientifique)
Cited by 35
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422